Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors.
Clin Cancer Res
; 29(18): 3592-3602, 2023 09 15.
Article
in En
| MEDLINE
| ID: mdl-37491846
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Carcinoma, Adenoid Cystic
/
Neoplasms
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2023
Type:
Article
Affiliation country:
Spain